Scientific Evidence for the Treatment of Children with Irritable Bowel Syndrome

Paolo Quitadamo1, Sara Isoldi2, Saverio Mallardo2

  • 1Department of Pediatrics, A.O.R.N. Santobono-Pausilipon, Naples, Italy.

Current Pediatric Reviews
|January 28, 2021
PubMed

Insights

Pediatric Irritable Bowel Syndrome (IBS) significantly impacts children's quality of life. This review evaluates evidence for current treatments like medications, diet, and therapies in children with IBS.

Area of Science:

  • Gastroenterology
  • Pediatrics
  • Clinical Medicine

Background:

  • Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal disorder in children.
  • IBS negatively affects children's quality of life, characterized by abdominal pain, altered stool form, and frequency.
  • The precise etiology of pediatric IBS remains unclear, and optimal treatments are lacking.

Purpose of the Study:

  • To review and evaluate the scientific evidence supporting the efficacy of current treatments for IBS in children.
  • To provide an overview of available therapeutic options, including pharmacological, dietary, and biopsychosocial interventions.

Main Methods:

  • Systematic review of scientific literature.
  • Evaluation of evidence for drug therapies, dietary interventions, and biopsychosocial approaches.
  • Analysis of treatment efficacy specifically in pediatric populations.

Main Results:

  • The review assesses the scientific evidence for various treatment modalities.
  • Efficacy data for pharmacological, dietary, and biopsychosocial therapies in pediatric IBS are examined.
  • Identification of gaps in current treatment effectiveness and evidence.

Conclusions:

  • Current treatment options for pediatric IBS include medications, dietary changes, and biopsychosocial therapies.
  • Further research is needed to establish optimal and evidence-based treatment strategies for children with IBS.
  • This review highlights the need for improved therapeutic approaches to manage pediatric IBS effectively.

Related Concept Videos

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
478
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
510
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
481
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
503
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
662
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
431